APOA1 |
APOA1: Apolipoprotein A-I precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
1.132 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
O
|
EDA |
IPI00023765 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
IL4 |
IL4: Interleukin-4 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.132 |
Evidence |
|
MAPK10 |
MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
DRD2 |
DRD2: D(2) dopamine receptor |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
APOE |
APOE: Apolipoprotein E precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
NOG |
NOG: Noggin precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
1.132 |
Evidence |
O
|
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
O
|
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
|
MMP13 |
MMP13: Collagenase 3 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.132 |
Evidence |
|
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.132 |
Evidence |
|
IL6 |
IL6, IFNB2: Interleukin-6 precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
1.132 |
Evidence |
O
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
GTF2F2 |
IPI00329767 |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
1.13 |
Evidence |
O
|
CREBBP |
CREBBP, CBP: CREB-binding protein |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
1.13 |
Evidence |
O
|
NRAS |
HRAS, HRAS1: GTPase HRas precursor |
RASSF1 |
RASSF1, RDA32: Ras association domain-containing protein 1 |
1.122 |
Evidence |
|